Good evening :)
Place Order
Add to Watchlist

Jenburkt Pharmaceuticals Ltd

JENBURPH

Jenburkt Pharmaceuticals Ltd

JENBURPH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹297 cr, stock is ranked 1,831
Moderate RiskStock is 2.54x as volatile as Nifty
670.000.75% (-5.05)
670.000.75% (-5.05)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹297 cr, stock is ranked 1,831
Moderate RiskStock is 2.54x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹297 cr, stock is ranked 1,831
Moderate RiskStock is 2.54x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
12.162.432.13%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.465.110.70%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jenburkt Pharmaceuticals Limited is engaged in the manufacture of pharmaceutical formulations. The Company offers prescription and over-the-counter drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 3.74%, vs industry avg of 8.45%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.06% to 0.04%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 7.41%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue87.3196.32106.27118.06126.05123.11113.60128.93141.87142.07
Raw Materialssubtract26.5828.8932.5130.5138.7533.5526.9133.7231.67106.68
Power & Fuel Costsubtract0.520.570.530.610.590.590.500.610.76
Employee Costsubtract18.9921.4925.2127.6931.2036.5132.3836.4938.81
Selling & Administrative Expensessubtract23.2926.1126.6127.3028.1025.4623.0324.3229.03
Operating & Other expensessubtract0.580.07-1.274.78-0.953.036.621.596.12
Depreciation/Amortizationsubtract2.661.991.791.501.352.302.041.902.262.26
Interest & Other Itemssubtract0.360.380.410.410.390.530.470.430.370.32
Taxes & Other Itemssubtract4.706.056.978.056.836.275.147.588.258.32
EPS20.7123.1629.0637.2643.1232.4035.9748.5754.6555.49
DPS6.307.208.109.0010.208.1010.2012.0014.4014.40
Payout ratio0.300.310.280.240.240.250.280.250.260.26

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jenburkt Pharmaceuticals Ltd12.112.432.13%
Sun Pharmaceutical Industries Ltd35.105.010.93%
Cipla Ltd35.284.170.69%
Dr Reddy's Laboratories Ltd21.344.130.69%

Price Comparison

Compare JENBURPH with any stock or ETF
Compare JENBURPH with any stock or ETF
JENBURPH
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding47.42%0.00%0.00%1.38%51.21%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep4.37%4.79%3.49%2.70%1.79%1.38%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 2.20%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹22.00 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 19, 2023

Final
Final | Div/Share: ₹14.40

Dividend/Share

14.40

Ex DateEx Date

Jul 19, 2023

Cash Dividend

Ex DateEx DateJul 21, 2022

Final
Final | Div/Share: ₹12.00

Dividend/Share

12.00

Ex DateEx Date

Jul 21, 2022

Cash Dividend

Ex DateEx DateAug 30, 2021

Final
Final | Div/Share: ₹10.20

Dividend/Share

10.20

Ex DateEx Date

Aug 30, 2021

Cash Dividend

Ex DateEx DateMar 18, 2020

Interim
Interim | Div/Share: ₹8.10

Dividend/Share

8.10

Ex DateEx Date

Mar 18, 2020

Cash Dividend

Ex DateEx DateJul 22, 2019

Final
Final | Div/Share: ₹10.20

Dividend/Share

10.20

Ex DateEx Date

Jul 22, 2019